NEW MEDICATIONS FOR ASTHMA
Identifieur interne : 002451 ( Main/Exploration ); précédent : 002450; suivant : 002452NEW MEDICATIONS FOR ASTHMA
Auteurs : Rita K. Cydulka ; Howard E. Jarvis IiiSource :
- Emergency Medicine Clinics of North America [ 0733-8627 ] ; 2000.
English descriptors
- Teeft :
- Acute asthma, Acute asthma exacerbation, Acute asthma exacerbations, Adverse effects, Agonist, Airway, Albuterol, Allergy, Allergy clin, Allergy clin immunol, Aminophylline, Asthma, Asthma exacerbation, Asthma symptoms, Asthma therapy, Asthmatic, Asthmatic patients, Beta, Beta agonists, Chronic asthma, Clin, Corticosteroid, Crit, Cydulka, Cydulka jarvis, Dos, Emerg, Emergency department, Emergency medicine, Exacerbation, Greater improvement, Halothane, Heliox, Immunol, Inhaled, Inhaled budesonide, Inhaled corticosteroid, Inhaled corticosteroids, Inhaled heparin, Inhaled steroids, Intravenous, Ipratropium, Ipratropium bromide, Jarvis, Ketamine, Leukotriene, Leukotriene modifiers, Magnesium, Magnesium sulfate, Mechanical ventilation, Medication, Methotrexate, Monteleukast, Nebulized, Nebulized albuterol, Nebulized ipratropium, Nebulized salbutamol, Nebulizer, Nedocromil, Nedocromil sodium, Pefr, Pulmonary function, Randomized, Receptor, Refractory, Refractory asthma, Regimen, Respir, Respir crit care, Rodrigo, Salbutamol, Severe asthma, Severe asthma exacerbation, Severe asthma exacerbations, Severe exacerbations, Side effects, Significant improvement, Standard therapy, Steroid, Sulfate, Systemic corticosteroids, Theophylline.
Abstract
Asthma therapy continues to evolve based on the understanding that asthma is predominantly a chronic inflammatory disease. Many newer agents have been developed to target inflammatory changes, whereas many of the older agents are being administered in new ways. Some agents, such as magnesium and heliox, are used only in refractory cases of asthma, and their efficacy, although in certain cases marked, requires much further study before routine use can be advocated. This discussion reviews new medications, considers new ways to use established therapies, and comments on medications that are used only rarely and the role for which has not been clearly established. For a guide to current recommendations on asthma therapy, the reader is advised to refer to the 1997 NIH Guidelines for the Diagnosis and Management of Asthma.87
Url:
DOI: 10.1016/S0733-8627(05)70159-0
Affiliations:
Links toward previous steps (curation, corpus...)
- to stream Istex, to step Corpus: 000841
- to stream Istex, to step Curation: 000841
- to stream Istex, to step Checkpoint: 001268
- to stream Main, to step Merge: 002479
- to stream Main, to step Curation: 002451
Le document en format XML
<record><TEI wicri:istexFullTextTei="biblStruct"><teiHeader><fileDesc><titleStmt><title>NEW MEDICATIONS FOR ASTHMA</title><author><name sortKey="Cydulka, Rita K" sort="Cydulka, Rita K" uniqKey="Cydulka R" first="Rita K." last="Cydulka">Rita K. Cydulka</name></author><author><name sortKey="Jarvis Iii, Howard E" sort="Jarvis Iii, Howard E" uniqKey="Jarvis Iii H" first="Howard E." last="Jarvis Iii">Howard E. Jarvis Iii</name></author></titleStmt><publicationStmt><idno type="wicri:source">ISTEX</idno><idno type="RBID">ISTEX:4D6E638F0FCC6A96D4C9EB864C90B78D696AA0C0</idno><date when="2000" year="2000">2000</date><idno type="doi">10.1016/S0733-8627(05)70159-0</idno><idno type="url">https://api.istex.fr/ark:/67375/6H6-14H0LZD2-K/fulltext.pdf</idno><idno type="wicri:Area/Istex/Corpus">000841</idno><idno type="wicri:explorRef" wicri:stream="Istex" wicri:step="Corpus" wicri:corpus="ISTEX">000841</idno><idno type="wicri:Area/Istex/Curation">000841</idno><idno type="wicri:Area/Istex/Checkpoint">001268</idno><idno type="wicri:explorRef" wicri:stream="Istex" wicri:step="Checkpoint">001268</idno><idno type="wicri:doubleKey">0733-8627:2000:Cydulka R:new:medications:for</idno><idno type="wicri:Area/Main/Merge">002479</idno><idno type="wicri:Area/Main/Curation">002451</idno><idno type="wicri:Area/Main/Exploration">002451</idno></publicationStmt><sourceDesc><biblStruct><analytic><title level="a">NEW MEDICATIONS FOR ASTHMA</title><author><name sortKey="Cydulka, Rita K" sort="Cydulka, Rita K" uniqKey="Cydulka R" first="Rita K." last="Cydulka">Rita K. Cydulka</name><affiliation></affiliation><affiliation><wicri:noCountry code="subField">HEJ)</wicri:noCountry></affiliation></author><author><name sortKey="Jarvis Iii, Howard E" sort="Jarvis Iii, Howard E" uniqKey="Jarvis Iii H" first="Howard E." last="Jarvis Iii">Howard E. Jarvis Iii</name><affiliation><wicri:noCountry code="subField">HEJ)</wicri:noCountry></affiliation></author></analytic><monogr></monogr><series><title level="j">Emergency Medicine Clinics of North America</title><title level="j" type="abbrev">EMC</title><idno type="ISSN">0733-8627</idno><imprint><publisher>ELSEVIER</publisher><date type="published" when="2000">2000</date><biblScope unit="volume">18</biblScope><biblScope unit="issue">4</biblScope><biblScope unit="page" from="789">789</biblScope><biblScope unit="page" to="801">801</biblScope></imprint><idno type="ISSN">0733-8627</idno></series></biblStruct></sourceDesc><seriesStmt><idno type="ISSN">0733-8627</idno></seriesStmt></fileDesc><profileDesc><textClass><keywords scheme="Teeft" xml:lang="en"><term>Acute asthma</term><term>Acute asthma exacerbation</term><term>Acute asthma exacerbations</term><term>Adverse effects</term><term>Agonist</term><term>Airway</term><term>Albuterol</term><term>Allergy</term><term>Allergy clin</term><term>Allergy clin immunol</term><term>Aminophylline</term><term>Asthma</term><term>Asthma exacerbation</term><term>Asthma symptoms</term><term>Asthma therapy</term><term>Asthmatic</term><term>Asthmatic patients</term><term>Beta</term><term>Beta agonists</term><term>Chronic asthma</term><term>Clin</term><term>Corticosteroid</term><term>Crit</term><term>Cydulka</term><term>Cydulka jarvis</term><term>Dos</term><term>Emerg</term><term>Emergency department</term><term>Emergency medicine</term><term>Exacerbation</term><term>Greater improvement</term><term>Halothane</term><term>Heliox</term><term>Immunol</term><term>Inhaled</term><term>Inhaled budesonide</term><term>Inhaled corticosteroid</term><term>Inhaled corticosteroids</term><term>Inhaled heparin</term><term>Inhaled steroids</term><term>Intravenous</term><term>Ipratropium</term><term>Ipratropium bromide</term><term>Jarvis</term><term>Ketamine</term><term>Leukotriene</term><term>Leukotriene modifiers</term><term>Magnesium</term><term>Magnesium sulfate</term><term>Mechanical ventilation</term><term>Medication</term><term>Methotrexate</term><term>Monteleukast</term><term>Nebulized</term><term>Nebulized albuterol</term><term>Nebulized ipratropium</term><term>Nebulized salbutamol</term><term>Nebulizer</term><term>Nedocromil</term><term>Nedocromil sodium</term><term>Pefr</term><term>Pulmonary function</term><term>Randomized</term><term>Receptor</term><term>Refractory</term><term>Refractory asthma</term><term>Regimen</term><term>Respir</term><term>Respir crit care</term><term>Rodrigo</term><term>Salbutamol</term><term>Severe asthma</term><term>Severe asthma exacerbation</term><term>Severe asthma exacerbations</term><term>Severe exacerbations</term><term>Side effects</term><term>Significant improvement</term><term>Standard therapy</term><term>Steroid</term><term>Sulfate</term><term>Systemic corticosteroids</term><term>Theophylline</term></keywords></textClass><langUsage><language ident="en">en</language></langUsage></profileDesc></teiHeader><front><div type="abstract">Asthma therapy continues to evolve based on the understanding that asthma is predominantly a chronic inflammatory disease. Many newer agents have been developed to target inflammatory changes, whereas many of the older agents are being administered in new ways. Some agents, such as magnesium and heliox, are used only in refractory cases of asthma, and their efficacy, although in certain cases marked, requires much further study before routine use can be advocated. This discussion reviews new medications, considers new ways to use established therapies, and comments on medications that are used only rarely and the role for which has not been clearly established. For a guide to current recommendations on asthma therapy, the reader is advised to refer to the 1997 NIH Guidelines for the Diagnosis and Management of Asthma.87</div></front></TEI><affiliations><list></list><tree><noCountry><name sortKey="Cydulka, Rita K" sort="Cydulka, Rita K" uniqKey="Cydulka R" first="Rita K." last="Cydulka">Rita K. Cydulka</name><name sortKey="Jarvis Iii, Howard E" sort="Jarvis Iii, Howard E" uniqKey="Jarvis Iii H" first="Howard E." last="Jarvis Iii">Howard E. Jarvis Iii</name></noCountry></tree></affiliations></record>Pour manipuler ce document sous Unix (Dilib)
EXPLOR_STEP=$WICRI_ROOT/Sante/explor/ChloroquineV1/Data/Main/Exploration
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 002451 | SxmlIndent | more
Ou
HfdSelect -h $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd -nk 002451 | SxmlIndent | more
Pour mettre un lien sur cette page dans le réseau Wicri
{{Explor lien
|wiki= Sante
|area= ChloroquineV1
|flux= Main
|étape= Exploration
|type= RBID
|clé= ISTEX:4D6E638F0FCC6A96D4C9EB864C90B78D696AA0C0
|texte= NEW MEDICATIONS FOR ASTHMA
}}
| This area was generated with Dilib version V0.6.33. |  |